Cover Image
市場調查報告書

血球分離的全球市場預測 ∼2020年:各應用、治療、技術及產品

Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 259318
出版日期 內容資訊 英文 188 Pages
訂單完成後即時交付
價格
Back to Top
血球分離的全球市場預測 ∼2020年:各應用、治療、技術及產品 Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020
出版日期: 2015年09月04日 內容資訊: 英文 188 Pages
簡介

血球分離,是透過醫療設備把血液依照成分分離,去除或留下某成分的狀態,再還給患者這樣的治療流程。2014年,全球血球分離市場規模是13億2,000萬美元,預計2020年達到24億8,800萬美元規模。

本報告提供血球分離市場趨勢相關調查分析、市場概要、各方法、各產品種類、各技術、各應用領域的考察,以及各地區分析、競爭情形等考察的結果彙整。

第1章 簡介

  • 調查目的
  • 市場定義
  • 對象市場
  • 貨幣
  • 調查上的規定
  • 相關利益者

第2章 調查方法

第3章 摘要整理

第4章 重要的考察

  • 調查資料
    • 二次資料
    • 一次資料
  • 市場規模預測
  • 市場明細及資料的三角分析
  • 市場佔有率預測
  • 調查的前提條件

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 市場成長的促進要素
    • 抑制因素
    • 機會
    • 課題

第6章 產業分析

  • 簡介
  • 產業趨勢
  • 波特的五力分析
  • 法規分析
    • 北美
    • 歐洲
    • 亞太地區

第7章 血球分離的全球市場:各治療

  • 簡介
  • 自動/血球分離血液採取(捐贈者血球分離)
  • 治療血球分離
    • 各疾病
    • 各治療

第8章 全球血球分離市場:各產品

  • 簡介
  • 設備
  • 消耗品

第9章 全球血球分離市場:各技術

  • 簡介
  • 離心分離
  • 膜分離技術

第10章 全球血球分離市場:各應用領域

  • 簡介
  • 血漿分離
  • 血小板分離
  • 紅血球分離
  • 低比重脂蛋白(LDL)
  • 其他

第11章 地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲地區
  • 全球其他地區

第12章 競爭情形

  • 簡介
  • 市場佔有率分析
  • 競業情形及趨勢
  • 契約、聯盟、合作、合資企業
  • M&A
  • 擴大
  • 新產品的銷售

第13章 企業簡介

第14章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 1407

Apheresis is an essential tool in modern medical practices in the blood industry. It is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of the blood and returns the remaining with or without extracorporeal treatment or replacement of separated components.

The global apheresis market is expected to reach USD 2.5 billion by 2020, growing at a CAGR of 11.2% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of blood disorders and chronic diseases, increasing demand for source plasma from biopharmaceutical companies, and increasing demand for blood for transfusion in surgical procedures and accident & trauma cases.

In this report, the apheresis market is segmented by procedure, product, technology, application, and region. The apheresis market, by procedure, is mainly segmented into apheresis/automated blood collection and therapeutic apheresis. In 2014, the automated blood collection segment accounted for the largest share of approximately 77.2% of the apheresis market, and is expected to grow at a CAGR of 10.7% during the forecast period. Growth in this segment is mainly attributed to the increasing severity of blood shortage and growing concern regarding blood safety, and increasing incidences of blood disorders and chronic diseases.

On the basis of applications, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share-46.5%-of the global apheresis market in 2014. The large share of plasmapheresis is attributed to the increasing demand of source plasma for transfusion from hospitals and for fractionation from biopharmaceutical companies.

In 2014, North America commanded the largest share of the global apheresis market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest share of 47.8% of global apheresis market in 2014. The U.S. is a prime market due to the easy access to advanced apheresis devices through well-established distribution channels, increased collection of source plasma, and increasing incidences of blood disorders and chronic diseases. On the other hand, Asia-Pacific is the fastest-growing region in the global apheresis market, mainly driven by the increasing demand of blood components for the treatment of the large patient population, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investments by leading players and respective government agencies in the region.

Major players in the apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan) and Therakos, Inc. (U.S.).

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.

This report provides insights on the following pointers:

  • Market Penetration:Comprehensive information on the product portfolios offered by the top players in the apheresis market. The report analyzes the apheresis market by procedure, product, technology, and application across all regions
  • Product Development/Innovation:Detailed insights on the upcoming trends, R&D activities, and new product launches in the apheresis market
  • Market Development:Comprehensive information on the lucrative emerging markets by procedure, product, technology, application, and region
  • Market Diversification:Exhaustive information about new products, growing regions, recent developments, and investments in the apheresis market
  • Competitive Assessment:In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the apheresis market

Available Customizations for This Report

With the given market data, MarketsandMarkets offers customizations as per the company's specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific apheresis market into South Korea, Australia, New Zealand, and others

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GROWTH POTENTIAL OF THE APHERESIS MARKET
  • 4.2. ASIA-PACIFIC: APHERESIS MARKET, BY APPLICATION (2014)
  • 4.3. U.S. APHERESIS MARKET, BY PRODUCT TYPE
  • 4.4. APHERESIS MARKET: REGIONAL MIX
  • 4.5. APHERESIS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCT TYPE
    • 5.2.2. BY PROCEDURE
    • 5.2.3. BY TECHNOLOGY
    • 5.2.4. BY APPLICATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. Rising prevalence of various diseases and related increase in Disability Adjusted Life Years (DALYs)
      • 5.3.1.2. Increasing demand for source plasma from biopharmaceutical companies and corresponding increase in source plasma collections
      • 5.3.1.3. Severity of blood shortage and growing concerns regarding blood safety
    • 5.3.2. MARKET RESTRAINTS
      • 5.3.2.1. High cost of apheresis devices and procedures
      • 5.3.2.2. Scarcity of qualified donors
    • 5.3.3. MARKET OPPORTUNITIES
      • 5.3.3.1. Extending reach of apheresis in the untapped pediatric segment
      • 5.3.3.2. Emerging economies with increasing investments from government bodies and leading players
    • 5.3.4. MARKET CHALLENGES
      • 5.3.4.1. Lack of awareness and challenges in donor recruitment

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. GROWING NUMBER OF AGREEMENTS AND PARTNERSHIPS
  • 6.3. PORTER'S FIVE FORCE ANALYSIS
    • 6.3.1. THREAT OF NEW ENTRANTS
    • 6.3.2. THREAT OF SUBSTITUTES
    • 6.3.3. BARGAINING POWER OF SUPPLIERS
    • 6.3.4. BARGAINING POWER OF BUYERS
    • 6.3.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.4. REGULATORY ANALYSIS
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
    • 6.4.2. EUROPE
    • 6.4.3. ASIA-PACIFIC
      • 6.4.3.1. Japan
      • 6.4.3.2. China
      • 6.4.3.3. India

7. GLOBAL APHERESIS MARKET, BY PROCEDURE

  • 7.1. INTRODUCTION
  • 7.2. AUTOMATED/APHERESIS BLOOD COLLECTION
  • 7.3. THERAPEUTIC APHERESIS
    • 7.3.1. THERAPEUTIC APHERESIS MARKET, BY DISEASE
      • 7.3.1.1. Neurological Disorders
      • 7.3.1.2. Blood Disorders
      • 7.3.1.3. Cardiovascular Disorders
      • 7.3.1.4. Renal Disorders
      • 7.3.1.5. Autoimmune Disorders
      • 7.3.1.6. Metabolic Disorders
      • 7.3.1.7. Other Disorders
    • 7.3.2. THERAPEUTIC APHERESIS MARKET, BY PROCEDURE
      • 7.3.2.1. Therapeutic Plasma Exchange (TPE)
      • 7.3.2.2. Therapeutic Cytapheresis
        • 7.3.2.2.1. Therapeutic Erythrocytapheresis
        • 7.3.2.2.2. Therapeutic Plateletphersis
        • 7.3.2.2.3. Leukapheresis
      • 7.3.2.3. Photopheresis
      • 7.3.2.4. Extracorporeal Immunoadsorption (ECI)
      • 7.3.2.5. Low-density Lipoprotein (LDL) Apheresis

8. GLOBAL APHERESIS MARKET, BY PRODUCT

  • 8.1. INTRODUCTION
  • 8.2. DEVICES
  • 8.3. DISPOSABLES

9. GLOBAL APHERESIS MARKET, BY TECHNOLOGY

  • 9.1. INTRODUCTION
  • 9.2. CENTRIFUGATION
    • 9.2.1. INTERMITTENT FLOW
    • 9.2.2. CONTINUOUS FLOW
  • 9.3. MEMBRANE SEPARATION

10. GLOBAL APHERESIS MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. PLASMAPHERESIS
  • 10.3. PLATELETPHERESIS
  • 10.4. ERYTHROCYTAPHERESIS
  • 10.5. LEUKAPHERESIS
  • 10.6. LOW DENSITY LIPOPROTEIN (LDL) APHERESIS
  • 10.7. OTHER APPLICATIONS

11. GEOGRAPHIC ANALYSIS

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE (ROE)
  • 11.4. ASIA-PACIFIC (APAC)
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA-PACIFIC
  • 11.5. LATIN AMERICA
    • 11.5.1. BRAZIL
    • 11.5.2. MEXICO
    • 11.5.3. REST OF LATIN AMERICA (ROLA)
  • 11.6. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
  • 12.4. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  • 12.5. MERGERS AND ACQUISITIONS
  • 12.6. EXPANSION
  • 12.7. NEW PRODUCT LAUNCHES

13. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 13.1. INTRODUCTION
  • 13.2. TERUMO BCT, INC.
  • 13.3. ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI GROUP)
  • 13.4. FRESENIUS SE & CO. KGAA
  • 13.5. HAEMONETICS CORPORATION
  • 13.6. CERUS CORPORATION
  • 13.7. B. BRAUN MELSUNGEN AG
  • 13.8. HEMACARE CORPORATION
  • 13.9. MEDICA S.P.A
  • 13.10. KAWASUMI LABORATORIES INC.
  • 13.11. KANEKA CORPORATION
  • 13.12. NIKKISO CO., LTD.
  • 13.13. THERAKOS, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS, 2011-2015
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: RISING PREVALENCE OF VARIOUS DISEASES AND RELATED INCREASE IN DISABILITY ADJUSTED LIFE YEARS (DALYS) TO DRIVE THE MARKET GROWTH
  • TABLE 2: GLOBAL PROJECTED DALYS, BY CAUSE, 2008 VS. 2015 VS. 2030
  • TABLE 3: HIGH COST OF APHERESIS DEVICES AND PROCEDURES TO RESTRICT MARKET GROWTH
  • TABLE 4: FREQUENCY OF BLOOD DONATIONS FROM HEALTHY DONORS
  • TABLE 5: EXTENDING REACH OF APHERESIS IN THE UNTAPPED PEDIATRIC SEGMENT OFFERS SIGNIFICANT OPPORTUNITIES FOR APHERESIS MARKET
  • TABLE 6: LACK OF AWARENESS & CHALLENGES IN DONOR RECRUITMENT WILL LIMIT THE WIDER ADOPTION AMONG HEALTHCARE PROVIDERS AND BLOOD BANKS
  • TABLE 7: GLOBAL APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL APHERESIS MARKET SIZE FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 10: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 11: NEUROLOGICAL DISEASES/DISORDERS TREATED BY THERAPEUTIC APHERESIS
  • TABLE 12: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE FOR BLOOD DISORDERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 14: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE FOR RENAL DISORDERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE FOR METABOLIC DISORDERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 18: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE FOR OTHER DISORDERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: GLOBAL THERAPEUTIC APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 20: GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: GLOBAL THERAPEUTIC CYTAPHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 22: GLOBAL THERAPEUTIC CYTAPHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 23: GLOBAL THERAPEUTIC ERYTHROCYTAPHERESIS DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: GLOBAL THERAPEUTIC PLATELETPHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 25: GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: GLOBAL PHOTOPHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 27: GLOBAL EXTRACORPOREAL IMMUNOADSORPTION MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: GLOBAL LDL APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: GLOBAL APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 30: APHERESIS DEVICES/SYSTEMS AVAILABLE IN THE MARKET
  • TABLE 31: GLOBAL APHERESIS DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: GLOBAL APHERESIS DISPOSABLES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: GLOBAL APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 34: CENTRIFUGATION-BASED APHERESIS DEVICES
  • TABLE 35: GLOBAL CENTRIFUGATION-BASED APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: GLOBAL CENTRIFUGATION-BASED APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 37: GLOBAL INTERMITTENT FLOW CENTRIFUGATION-BASED APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 38: GLOBAL CONTINUOUS FLOW CENTRIFUGATION-BASED APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: SIZE OF BLOOD COMPONENTS
  • TABLE 40: MEMBRANE SEPARATION-BASED APHERESIS DEVICES
  • TABLE 41: GLOBAL MEMBRANE SEPARATION-BASED APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 42: GLOBAL APHERESIS MARKET SIZE, BY APPLICATION, 2013 - 2020 (USD MILLION)
  • TABLE 43: TOTAL SOURCE PLASMA COLLECTION IN THE U.S. & EUROPE, 2005-2013 (THOUSAND LITERS)
  • TABLE 44: GLOBAL APHERESIS MARKET SIZE FOR PLASMAPHERESIS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 45: GLOBAL APHERESIS MARKET SIZE FOR PLATELETPHERESIS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 46: GLOBAL APHERESIS MARKET SIZE FOR ERYTHROCYTAPHERESIS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 47: GLOBAL APHERESIS MARKET SIZE FOR LEUKAPHERESIS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 48: GLOBAL APHERESIS MARKET SIZE FOR LDL APHERESIS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 49: GLOBAL APHERESIS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 50: GLOBAL APHERESIS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 51: GLOBAL APHERESIS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION)
  • TABLE 52: NORTH AMERICA: APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 53: NORTH AMERICA: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 54: NORTH AMERICA: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: NORTH AMERICA: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 56: NORTH AMERICA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 57: U.S.: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 58: U.S.: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: U.S.: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 60: U.S.: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 61: CANADA: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 62: CANADA: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: CANADA: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 64: CANADA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 65: EUROPE: APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 66: EUROPE: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 67: EUROPE: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: EUROPE: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 69: EUROPE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 70: GERMANY: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 71: GERMANY: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 72: GERMANY: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 73: GERMANY: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 74: FRANCE: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 75: FRANCE: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 76: FRANCE: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 77: FRANCE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 78: U.K.: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 79: U.K.: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 80: U.K.: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 81: U.K.: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 82: ITALY: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 83: ITALY: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 84: ITALY: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 85: ITALY: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 86: SPAIN: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 87: SPAIN: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 88: SPAIN: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 89: SPAIN: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 90: ROE: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 91: ROE: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 92: ROE: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 93: ROE: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 94: APAC: APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 95: APAC: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 96: APAC: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 97: APAC: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 98: APAC: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 99: JAPAN: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 100: JAPAN: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 101: JAPAN: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 102: JAPAN: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 103: CHINA: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 104: CHINA: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 105: CHINA: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 106: CHINA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 107: INDIA: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 108: INDIA: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 109: INDIA: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 110: INDIA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 111: ROAPAC: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 112: ROAPAC: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 113: ROAPAC: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 114: ROAPAC: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 115: LATIN AMERICA: APHERESIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 116: LATIN AMERICA: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 117: LATIN AMERICA: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 118: LATIN AMERICA: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 119: LATIN AMERICA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 120: BRAZIL: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 121: BRAZIL: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 122: BRAZIL: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 123: BRAZIL: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 124: MEXICO: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 125: MEXICO: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 126: MEXICO: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 127: MEXICO: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 128: ROLA: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 129: ROLA: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 130: ROLA: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 131: ROLA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 132: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY PROCEDURE, 2013-2020 (USD MILLION)
  • TABLE 133: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 134: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 135: MIDDLE EAST AND AFRICA: APHERESIS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 136: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2011-2015
  • TABLE 137: MERGERS AND ACQUISITIONS, 2011-2015
  • TABLE 138: EXPANSIONS, 2011-2015
  • TABLE 139: NEW PRODUCT LAUNCHES, 2011-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL APHERESIS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL APHERESIS MARKET SIZE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 7: GLOBAL APHERESIS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: GLOBAL APHERESIS MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: GLOBAL APHERESIS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: GEOGRAPHIC SNAPSHOT OF GLOBAL APHERESIS MARKET, 2014
  • FIGURE 11: RISING PREVALENCE AND INCIDENCE OF CHRONIC DISEASES TO DRIVE THE APHERESIS MARKET DURING FORECAST PERIOD
  • FIGURE 12: PLASMAPHERESIS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA-PACIFIC APHERESIS MARKET IN 2014
  • FIGURE 13: DISPOSABLES IS PROJECTED TO COMMAND LARGEST SHARE IN THE U.S. APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 14: NORTH AMERICA TO DOMINATE THE APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: CHINA, INDIA, & REST OF ASIA-PACIFIC ARE PROJECTED TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: APHERESIS MARKET SEGMENTATION, BY PRODUCT TYPE
  • FIGURE 17: APHERESIS MARKET SEGMENTATION, BY PROCEDURE
  • FIGURE 18: APHERESIS MARKET SEGMENTATION, BY TECHNOLOGY
  • FIGURE 19: APHERESIS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 20: APHERESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 21: TYPE OF PLASMA PROCESSED WORLDWIDE, 1996-2012 (THOUSAND LITERS)
  • FIGURE 22: SOURCE PLASMA COLLECTIONS IN THE U.S. & EUROPE, 2005-2013 (THOUSAND LITERS)
  • FIGURE 23: PORTER'S FIVE FORCES ANALYSIS: APHERESIS MARKET
  • FIGURE 24: THERAPEUTIC APHERESIS IS PROJECTED TO BE THE FASTEST-GROWING SEGMENT OF THE APHERESIS PROCEDURES MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: DISPOSABLES ARE PROJECTED TO BE THE FASTEST-GROWING SEGMENT OF APHERESIS PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: CENTRIFUGATION TECHNOLOGY SEGMENT IS PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 27: PLASMAPHERESIS IS PROJECTED TO BE THE FASTEST-GROWING SEGMENT IN THE APHERESIS MARKET DURING FORECAST PERIOD (2015-2020)
  • FIGURE 28: NORTH AMERICA TO DOMINATE THE APHERESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 29: NORTH AMERICA HOLDS THE LARGEST SHARE OF THE GLOBAL APHERESIS MARKET IN 2015
  • FIGURE 30: EUROPE: THE SECOND LARGEST APHERESIS MARKET
  • FIGURE 31: AGREEMENTS/COLLABORATIONS/PARTNERSHIPS WERE THE MOST-PREFERRED STRATEGIES BETWEEN 2011 AND 2015
  • FIGURE 32: GLOBAL APHERESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 33: BATTLE FOR MARKET SHARE: AGREEMENTS/COLLABORATIONS/PARTNERSHIPS, THE KEY STRATEGIES
  • FIGURE 34: GEOGRAPHIC REVENUE MIX OF MAJOR PLAYERS
  • FIGURE 35: COMPANY SNAPSHOT: TERUMO CORPORATION
  • FIGURE 36: COMPANY SNAPSHOT: ASAHI KASEI GROUP
  • FIGURE 37: COMPANY SNAPSHOT: FRESENIUS MEDICAL CARE
  • FIGURE 38: COMPANY SNAPSHOT: FRESENIUS KABI
  • FIGURE 39: COMPANY SNAPSHOT: HAEMONETICS CORPORATION
  • FIGURE 40: COMPANY SNAPSHOT: CERUS CORPORATION
  • FIGURE 41: COMPANY SNAPSHOT: B. BRAUN MELSUNGEN AG
  • FIGURE 42: COMPANY SNAPSHOT: KAWASUMI LABORATORIES INC.
  • FIGURE 43: COMPANY SNAPSHOT: KANEKA CORPORATION
  • FIGURE 44: COMPANY SNAPSHOT: NIKKISO CO., LTD.
Back to Top